Ran Nussbaum
Affiliations
- at Keros Therapeutics Inc. (KROS), 2025-06-11
- Director at Urogen Pharma Ltd. (URGN), 2023-02-28
- Director at Eloxx Pharmaceuticals Inc. (ELOX), 2022-06-17
- Director at Prevail Therapeutics Inc. (PRVL), 2021-01-26
- Director at Arqule Inc (ARQL), 2020-01-16
- Director at Vbi Vaccines Inc (VBIV), 2017-11-01
- Director at Kite Pharma Inc. (KITE), 2017-10-06
- Large Shareholder at Arno Therapeutics Inc (ARNI), 2016-09-08
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| ELOX | $1.35 | 592,592 | $799,999.20 | 616,592 | 2021-05-13 | Filing |
| ELOX | $1.35 | 1,422,222 | $1,919,999.70 | 1,989,551 | 2021-05-13 | Filing |
| ELOX | $1.35 | 2,630,487 | $3,551,157.45 | 3,679,797 | 2021-05-13 | Filing |
| ELOX | $1.35 | 1,280,624 | $1,728,842.40 | 1,791,470 | 2021-05-13 | Filing |
| KROS | $50.00 | 6,000 | $300,000.00 | 155,262 | 2020-11-17 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| KITE | $56.08 | 24,070 | $1,349,845.60 | 0 | 2015-06-02 | Filing |
| KITE | $55.27 | 200,604 | $11,087,383.08 | 24,070 | 2015-06-02 | Filing |
| KITE | $57.38 | 7,800 | $447,564.00 | 224,674 | 2015-06-01 | Filing |
| KITE | $56.44 | 3,754 | $211,875.76 | 232,474 | 2015-06-01 | Filing |
| KITE | $55.05 | 69,206 | $3,809,790.30 | 236,228 | 2015-06-01 | Filing |